Stocks · News reference
Medicenna Therapeutics Q1 EPS $(0.06), Inline
Medicenna Therapeutics (TSX:MDNA) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is unchanged from the same period last year.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 14, 2026, 11:11 AM
- Checked
- Aug 14, 2026, 11:11 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
No Linked Headlines Yet
The feed will populate when a captured headline is linked to this market.